147 related articles for article (PubMed ID: 33600094)
1. Utilization of biotechnological drugs in rare diseases requiring the use of off-label drugs in children in Turkey.
Kırmızı Nİ; Aydın V; Akıcı N; Bayar B; Akıcı A
Turk J Med Sci; 2021 Aug; 51(4):1791-1799. PubMed ID: 33600094
[TBL] [Abstract][Full Text] [Related]
2. Off-label drug use in pediatric patients: a comparative analysis with nationwide routine prescription data.
Akıcı N; Kırmızı Nİ; Aydın V; Bayar B; Aksoy M; Akıcı A
Turk J Pediatr; 2020; 62(6):949-961. PubMed ID: 33372433
[TBL] [Abstract][Full Text] [Related]
3. Analysis of clinical trials and off-label drug use in hospitalized pediatric patients.
Roldán T; Villamañán E; Ruano M; Larrubia Y; Gómez-Salcedo P; Herrero A
Arch Argent Pediatr; 2014 Jun; 112(3):249-53. PubMed ID: 24862807
[TBL] [Abstract][Full Text] [Related]
4. A nationwide evaluation of off-label drug utilization in Turkey.
Özdamar EN; Akıcı A; Alkan A; Bayar B; Gürsöz H
Turk J Med Sci; 2017 Aug; 47(4):1229-1238. PubMed ID: 29156868
[TBL] [Abstract][Full Text] [Related]
5. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
[TBL] [Abstract][Full Text] [Related]
6. Drug utilization and off-label drug use among Spanish emergency room paediatric patients.
Morales-Carpi C; Estañ L; Rubio E; Lurbe E; Morales-Olivas FJ
Eur J Clin Pharmacol; 2010 Mar; 66(3):315-20. PubMed ID: 19936729
[TBL] [Abstract][Full Text] [Related]
7. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications.
Dos Santos L; Heineck I
Farm Hosp; 2012; 36(4):180-6. PubMed ID: 22030161
[TBL] [Abstract][Full Text] [Related]
8. Off-label and unlicensed utilization of drugs in a Brazilian pediatric hospital.
Pereira Gomes V; Melo da Silva K; Oliveira Chagas S; dos Santos Magalhães IR
Farm Hosp; 2015 May; 39(3):176-80. PubMed ID: 26005894
[TBL] [Abstract][Full Text] [Related]
9. Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran.
Kouti L; Aletayeb M; Aletayeb SMH; Hardani AK; Eslami K
BMC Pediatr; 2019 Jan; 19(1):3. PubMed ID: 30609923
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.
Borges AP; Campos MS; Pereira LR
Int J Clin Pharm; 2013 Jun; 35(3):425-31. PubMed ID: 23430533
[TBL] [Abstract][Full Text] [Related]
11. Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review.
Magalhães J; Rodrigues AT; Roque F; Figueiras A; Falcão A; Herdeiro MT
Eur J Clin Pharmacol; 2015 Jan; 71(1):1-13. PubMed ID: 25318905
[TBL] [Abstract][Full Text] [Related]
12. Off-label uses of Aflibercept, Ranibizumab and Dexamethasone implant for diabetic retinopathy in Turkey.
Yilmaz M; Citirik M; Rahmanlar H; Alkan A; Gursoz H
Rom J Ophthalmol; 2022; 66(4):304-309. PubMed ID: 36589330
[No Abstract] [Full Text] [Related]
13. Use of off-label nephrology-related drugs in hospitalized pediatric patients: a retrospective study.
Yasinta M; Che RC; Hu CY; Du XH; Ding GX; Huang SM; Chen Y; Zhang AH
World J Pediatr; 2016 May; 12(2):236-42. PubMed ID: 26684307
[TBL] [Abstract][Full Text] [Related]
14. [Situation analysis of off-label drug use in China].
Rui-Xue HU; Mei MO; Dan-Dan YU; Hui-Min LI; Xing L; Xiao-Jiao D; Yu-Bo G
Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4277-4284. PubMed ID: 33164415
[TBL] [Abstract][Full Text] [Related]
15. Unlicensed and off-label drug use in an Irish neonatal intensive care unit: a prospective cohort study.
Kieran EA; O'Callaghan N; O'Donnell CP
Acta Paediatr; 2014 Apr; 103(4):e139-42. PubMed ID: 24397831
[TBL] [Abstract][Full Text] [Related]
16. Unlicensed and Off-Label Medication Use in Pediatric and Neonatal Intensive Care Units: No Change Over a Decade.
Nir-Neuman H; Abu-Kishk I; Toledano M; Heyman E; Ziv-Baran T; Berkovitch M
Adv Ther; 2018 Jul; 35(7):1122-1132. PubMed ID: 29949042
[TBL] [Abstract][Full Text] [Related]
17. Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field.
Castañeda-Sanabria J; Hajage D; Le Jouan M; Perozziello A; Tubach F
Eur J Clin Pharmacol; 2016 Jun; 72(6):737-46. PubMed ID: 26915814
[TBL] [Abstract][Full Text] [Related]
18. Paediatric drug use with focus on off-label prescriptions at Swedish hospitals - a nationwide study.
Kimland E; Nydert P; Odlind V; Böttiger Y; Lindemalm S
Acta Paediatr; 2012 Jul; 101(7):772-8. PubMed ID: 22404126
[TBL] [Abstract][Full Text] [Related]
19. Current practice and awareness of pediatric off-label drug use in Shanghai, China -a questionnaire-based study.
Mei M; Xu H; Wang L; Huang G; Gui Y; Zhang X
BMC Pediatr; 2019 Aug; 19(1):281. PubMed ID: 31409339
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of off-label anti-vascular endothelial growth factor and steroid implant medication uses in macular edema due to retinal vein occlusion in Turkey.
Yilmaz M; Citirik M; Rahmanlar H; Alkan A; Gursoz H
J Clin Pharm Ther; 2022 Dec; 47(12):2101-2106. PubMed ID: 36543255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
